A Spanish version the page you have requested doesn't exist. Please click continue to to be navigated to the page, or click Cancel to remain on the current page.

Let's spread the word about Immunotherapy! Click to share this page with your community.

CRI featured in USA Today’s End-of-Year Charity Giving Advice

October 06, 2017

Many of our supporters already know that the Cancer Research Institute is among the highest rated cancer charities, but it’s always nice to see that acknowledged by third parties. USA Today’s recent article, “Breast cancer charities: Where to give – and where to avoid” (October 3, 2017), includes CRI among 12 top-rated cancer charities within a subset of organizations doing good work in breast cancer as well as other forms of cancer.

Why is this important to donors? Charity watchdog organizations like the American Institute of Philanthropy, which provided the data cited in the article, rate charity performance based on the services they provide and how much good they are able to do for society with the money they receive from donors. This provides assurance for donors as they consider where to invest their philanthropic dollars. It also helps donors avoid giving to fraudulent, mismanaged, or inefficient organizations.

At CRI we recognize that those who are generous enough to give to us are doing so because they want to make a true difference in the fight against cancer, and to help us bring the hope of more effective treatments to more patients. We strive to keep our overhead costs very low so that we can put the vast majority of donor funds into our programs. In addition to the A rating from Charity Watch, we have a 4-out-of-4-star rating from Charity Navigator, bear the GuideStar Exchange Seal, and we are a member of the Better Business Bureau’s Wise Giving Alliance. Numerous donors have told us that these high ratings were a factor in their selecting us as the recipient of their philanthropic efforts.

To all our supporters, we say “thank you!”, and we will continue to prudently and effectively invest the funds entrusted to us for the benefit of cancer patients. As we approach the “season of giving” at the end of the year, the USA Today article is a good reminder to all of us to do our research and be sure that our money is going where it will do the most good.

Subscribe to Our Email Newsletter. Get the latest cancer immunotherapy updates

*Immunotherapy results may vary from patient to patient.